The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates

Author:

Buhigas Claudia,Warren Anne Y.,Leung Wing-Kit,Whitaker Hayley C.,Luxton Hayley J.,Hawkins Steve,Kay Jonathan,Butler Adam,Xu Yaobo,Woodcock Dan J.,Merson Sue,Frame Fiona M.,Sahli Atef,Abascal Federico,Gihawi Abraham,Lambert Adam,Thompson Alan,Futreal Andrew,Menzies Andrew,Baddage Anne,Ng Anthony,Sahil Atef,Kremeyer Barbara,Al-Lazikani Bissan,Massie Charlie,Greenman Christopher,Ogden Christopher,Verrill Clare,Fisher Cyril,Berney Dan,Burns Dan,Leongamornlert Daniel,Jones David,Nicol David,Wedge David,Cahill Declan,Easton Douglas,Rowe Edward,Riabchenko Ekaterina,Bancroft Elizabeth,Mayer Erik,Anokian Ezequiel,Hamdy Freddie,Park Gahee,Pelvender Gill,Leeman Gregory,Gundem Gunes,Zhang Hongwei,Mills Ian G.,Zhang Jingjing,Teague Jon,Zamora Jorge,Karaszi Katalin,Raine Kieran,Matthews Lucy,Stebbings Lucy,Alexandrov Ludmil B.,Marsden Luke,Ahmed Mahbubl,Nykter Matti,Ghori Mohammed,Livni Naomi,Dennis Nening,Van As Nicholas,Camacho Niedzica,Shah Nimish,Kumar Pardeep,Van Loo Peter,Lach Radoslaw,Edwards Sandra,Pita Sara,Field Sarah J.,Thomas Sarah,Tavaré Simon,Scalabrino Stefania,Hazell Steven,McLaren Stuart,Visakorpi Tapio,Mitchell Thomas J.,Dudderidge Tim,Dadaev Tokhir,McDermott Ultan,Bo Valeria,Haberland Valeriia,Gnanapragasam Vincent,Khoo Vincent,Howat William,Jie-Lu Yong,Yu Yongwei,Kote-Jarai Zsofia,Martincorena Iñigo,Bova G. Steven,Foster Christopher S.,Campbell Peter,Maitland Norman J.,Neal David E.,Massie Charlie E.,Lynch Andy G.,Eeles Rosalind A.,Cooper Colin S.,Wedge David C.,Brewer Daniel S.,

Abstract

Abstract Background Up to 80% of cases of prostate cancer present with multifocal independent tumour lesions leading to the concept of a field effect present in the normal prostate predisposing to cancer development. In the present study we applied Whole Genome DNA Sequencing (WGS) to a group of morphologically normal tissue (n = 51), including benign prostatic hyperplasia (BPH) and non-BPH samples, from men with and men without prostate cancer. We assess whether the observed genetic changes in morphologically normal tissue are linked to the development of cancer in the prostate. Results Single nucleotide variants (P = 7.0 × 10–03, Wilcoxon rank sum test) and small insertions and deletions (indels, P = 8.7 × 10–06) were significantly higher in morphologically normal samples, including BPH, from men with prostate cancer compared to those without. The presence of subclonal expansions under selective pressure, supported by a high level of mutations, were significantly associated with samples from men with prostate cancer (P = 0.035, Fisher exact test). The clonal cell fraction of normal clones was always higher than the proportion of the prostate estimated as epithelial (P = 5.94 × 10–05, paired Wilcoxon signed rank test) which, along with analysis of primary fibroblasts prepared from BPH specimens, suggests a stromal origin. Constructed phylogenies revealed lineages associated with benign tissue that were completely distinct from adjacent tumour clones, but a common lineage between BPH and non-BPH morphologically normal tissues was often observed. Compared to tumours, normal samples have significantly less single nucleotide variants (P = 3.72 × 10–09, paired Wilcoxon signed rank test), have very few rearrangements and a complete lack of copy number alterations. Conclusions Cells within regions of morphologically normal tissue (both BPH and non-BPH) can expand under selective pressure by mechanisms that are distinct from those occurring in adjacent cancer, but that are allied to the presence of cancer. Expansions, which are probably stromal in origin, are characterised by lack of recurrent driver mutations, by almost complete absence of structural variants/copy number alterations, and mutational processes similar to malignant tissue. Our findings have implications for treatment (focal therapy) and early detection approaches.

Funder

Prostate Cancer UK

Cancer Research UK

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3